TRANSFORM II Trial Reaches Enrollment Milestone: Paving the Way for Innovative Heart Treatments The TRANSFORM II clinical trial successfully enrolls over 1,800 patients, comparing MagicTouch SCB with Everolimus-Eluting Stent for treating coronary artery disease.

TRANSFORM II Trial Reaches Enrollment Milestone: Paving the Way for Innovative Heart Treatments #USA #Cleveland #MagicTouch_SCB #Everolimus_Stent #TRANSFORM_II